Page last updated: 2024-11-02

fenclonine and Metabolic Diseases

fenclonine has been researched along with Metabolic Diseases in 2 studies

Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research Excerpts

ExcerptRelevanceReference
"Both groups of carcinoid patients had a comparable decrease in their insulinogenic index."1.25Glucose intolerance in the carcinoid syndrome. ( Bivens, CH; Feldman, JM; Lebovitz, HE; Plonk, JW, 1975)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feldman, JM1
Plonk, JW1
Bivens, CH1
Lebovitz, HE1
Delvalle, JA1
Dienel, G1
Greengard, O1

Other Studies

2 other studies available for fenclonine and Metabolic Diseases

ArticleYear
Glucose intolerance in the carcinoid syndrome.
    Diabetes, 1975, Volume: 24, Issue:7

    Topics: Adult; Aged; Carcinoid Tumor; Cyproheptadine; Diabetes Mellitus; Female; Fenclonine; Glucose; Glucos

1975
Comparison of alpha-methylphenylalanine and p-chlorophenylalanine as inducers of chronic hyperphenylalaninaemia in developing rats.
    The Biochemical journal, 1978, Mar-15, Volume: 170, Issue:3

    Topics: Animals; Brain; Fenclonine; Liver; Metabolic Diseases; Methyltyrosines; Phenylalanine; Phenylalanine

1978